Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)

NCT06842407 · clinicaltrials.gov ↗
RECRUITING
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Checkmab S.r.l.

Collaborators